Stock Price
9.52
Daily Change
-0.07 -0.75%
Monthly
7.13%
Yearly
-43.77%
Q2 Forecast
9.28

EPS Reference Time Actual Consensus Previous
2026-05-05 FY2026Q1 0.08 0.19
2026-03-04 FY2025Q4 0.23 0.23 0.25
2025-10-29 FY2025Q3 0.09 0.13 0.13
2025-07-29 FY2025Q2 0.22 0.27 0.29
2025-05-06 FY2025Q1 0.19 0.19 0.20



Peers Price Chg Day Year Date
Amplifon 9.52 -0.07 -0.75% -43.77% Apr/24
Avanos Medical 24.66 -0.05 -0.20% 99.68% Apr/24
Brookdale Senior Living 13.88 0.24 1.76% 120.32% Apr/24
Cencora 308.19 -3.20 -1.03% 7.80% Apr/24
Diasorin 59.80 -0.18 -0.30% -39.62% Apr/24
Encompass Health 101.98 0.12 0.12% -10.05% Apr/24
Enovis 24.10 1.29 5.66% -31.34% Apr/24
GE HealthCare Technologies 68.83 -1.06 -1.52% 0.60% Apr/24
Pediatrix Medical Group 23.04 0.28 1.23% 7.31% Apr/24
Veradigm 4.35 0 0% -1.14% Apr/24

Indexes Price Day Year Date
IT40 47656 -251.30 -0.52% 27.60% Apr/24
EU600 611 -3.55 -0.58% 17.33% Apr/24

Amplifon traded at 9.52 this Friday April 24th, decreasing 0.07 or 0.75 percent since the previous trading session. Looking back, over the last four weeks, Amplifon lost 7.13 percent. Over the last 12 months, its price fell by 43.77 percent. Looking ahead, we forecast Amplifon to be priced at 9.28 by the end of this quarter and at 8.57 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).